Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

BioCryst starts COVID-19 trial of broad-spectrum antiviral

fiercebiotechApril 13, 2020

Tag: BioCryst Pharmaceuticals , COVID-19 , galidesivir

PharmaSources Customer Service